Erythropoiesis News and Research

RSS
Ligand Pharmaceuticals reports preclinical study data on erythropoietin receptor agonists

Ligand Pharmaceuticals reports preclinical study data on erythropoietin receptor agonists

Amgen to present data on Nplate studies for chronic ITP at ASH Annual Meeting

Amgen to present data on Nplate studies for chronic ITP at ASH Annual Meeting

Keryx announces positive top-line results from Zerenex Phase 3 study for hyperphosphatemia

Keryx announces positive top-line results from Zerenex Phase 3 study for hyperphosphatemia

FG-2216 drug offers new treatment option for kidney disease-related anemia

FG-2216 drug offers new treatment option for kidney disease-related anemia

Vertex submits NDA for telaprevir for treating hepatitis C

Vertex submits NDA for telaprevir for treating hepatitis C

FibroGen to present FG-4592 phase 2a study of patients with stage 3-4 Chronic Kidney Disease and anemia

FibroGen to present FG-4592 phase 2a study of patients with stage 3-4 Chronic Kidney Disease and anemia

Bolder BioTechnology receives $1.2 million in Qualifying Therapeutic Discovery Project Grants

Bolder BioTechnology receives $1.2 million in Qualifying Therapeutic Discovery Project Grants

New guideline for using ESAs drugs in cancer patients

New guideline for using ESAs drugs in cancer patients

Amgen reports $3,816 million for 2010 third quarter revenue

Amgen reports $3,816 million for 2010 third quarter revenue

Amgen to review study results of ESA in chronic renal failure patients with FDA and CRDAC

Amgen to review study results of ESA in chronic renal failure patients with FDA and CRDAC

Weight-based taribavirin reduces anemia, increases sustained virologic response

Weight-based taribavirin reduces anemia, increases sustained virologic response

FG-4592 oral anemia therapy receives CTA approval from SFDA

FG-4592 oral anemia therapy receives CTA approval from SFDA

Phase 3 REALIZE study shows milestone in treatment development for hepatitis C

Phase 3 REALIZE study shows milestone in treatment development for hepatitis C

Research finds link between chronic heart failure, iron deficiency

Research finds link between chronic heart failure, iron deficiency

Hemoglobin variability does not increase mortality in European hemodialysis patients: Study

Hemoglobin variability does not increase mortality in European hemodialysis patients: Study

miRagen Therapeutics develop MicroRNA based therapeutics for cardiovascular and muscle disease

miRagen Therapeutics develop MicroRNA based therapeutics for cardiovascular and muscle disease

ArmaGen uses BBB molecular Trojan horse platform technology to create brain penetrating form of human EPO

ArmaGen uses BBB molecular Trojan horse platform technology to create brain penetrating form of human EPO

New research reports evaluating nephrology market in Europe released

New research reports evaluating nephrology market in Europe released

Rockwell Medical's SFP Phase IIb data accepted for presentation at XLVII ERA-EDTA Congress

Rockwell Medical's SFP Phase IIb data accepted for presentation at XLVII ERA-EDTA Congress

Data from Phase 2 clinical trials of Hematide/peginesatide presented at NKF Annual Meeting

Data from Phase 2 clinical trials of Hematide/peginesatide presented at NKF Annual Meeting